Burger, E.-M.; Hill, C.; Wodtke, R.; Zarschler, K.; Laube, M.; Donat, C.K.; Hauser, S.; Kopka, K.; Pietzsch, J.; Stadlbauer, S.
In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency. Pharmaceuticals 2025, 18, 1656.
https://doi.org/10.3390/ph18111656
AMA Style
Burger E-M, Hill C, Wodtke R, Zarschler K, Laube M, Donat CK, Hauser S, Kopka K, Pietzsch J, Stadlbauer S.
In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency. Pharmaceuticals. 2025; 18(11):1656.
https://doi.org/10.3390/ph18111656
Chicago/Turabian Style
Burger, Eva-Maria, Charlice Hill, Robert Wodtke, Kristof Zarschler, Markus Laube, Cornelius K. Donat, Sandra Hauser, Klaus Kopka, Jens Pietzsch, and Sven Stadlbauer.
2025. "In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency" Pharmaceuticals 18, no. 11: 1656.
https://doi.org/10.3390/ph18111656
APA Style
Burger, E.-M., Hill, C., Wodtke, R., Zarschler, K., Laube, M., Donat, C. K., Hauser, S., Kopka, K., Pietzsch, J., & Stadlbauer, S.
(2025). In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency. Pharmaceuticals, 18(11), 1656.
https://doi.org/10.3390/ph18111656
